GO
Loading...

Enter multiple symbols separated by commas

Biotech and Pharmaceuticals Medicine

More

  • Sept 2- The U.S. Food and Drug Administration approved Tesaro Inc's treatment for chemotherapy-induced nausea and vomiting in adults, the company said on Wednesday. The drug, known chemically as rolapitant, was approved in combination with other agents to prevent delayed nausea and vomiting associated with some forms of chemotherapy, Tesaro said.

  • CEOs big news can cause ripple effects for company Tuesday, 1 Sep 2015 | 6:20 PM ET

    NEW YORK— Yahoo CEO Marissa Mayer is promising to be away from the job for just a "limited time" when she gives birth to twins later this year, but the development only adds to the uncertainty some investors have long had about Yahoo. Mayer, 40, said Tuesday she and her husband are expecting twin girls in December and she said she plans to work through the pregnancy much...

  • Sept 1- Amgen Inc said its experimental bone drug was found to be more effective than an already marketed drug in a late-stage study. Amgen's drug, romosozumab, met the main goal of showing a significant difference over Eli Lilly& Co's teriparatide in improving total hip bone density by the 12th month in postmenopausal women with osteoporosis.

  • Amgen's bone drug succeeds in late-stage study Tuesday, 1 Sep 2015 | 4:49 PM ET

    Sept 1- Amgen Inc said its experimental bone drug was found to be more effective than an already marketed drug in a late-stage study. Amgen's drug, romosozumab, met the main goal of showing a significant difference over teriparatide in improving total hip bone density by the 12th month in postmenopausal women with osteoporosis. Osteoporosis is a condition...

  • NEW YORK, Sept 1- Ten weeks after closing its $8.4 billion purchase of Synageva BioPharma Corp, Alexion Pharmaceuticals Inc on Tuesday announced European approval for the key drug acquired through the deal, an enzyme-replacement therapy for an ultra-rare, life threatening disease. The treatments are awaiting U.S. approval decisions after receiving...

  • NEW YORK, Sept 1- Ten weeks after closing its $8.4 billion purchase of Synageva BioPharma Corp, Alexion Pharmaceuticals Inc on Tuesday announced European approval for two drugs acquired through the deal, both enzyme-replacement therapies for ultra-rare, life threatening diseases. The treatments are awaiting U.S. approval decisions after receiving...

  • Sept 1- Yahoo Inc Chief Executive Marissa Mayer announced she is pregnant with identical twin girls, likely due in December. "Since this is a unique time in Yahoo's transformation, I plan to approach the pregnancy and delivery as I did with my son three years ago, taking limited time away and working throughout," Mayer wrote in a blog post on Tuesday.

  • Sept 1- Canada's Valeant Pharmaceuticals International Inc said it has been granted an exclusive license by AstraZeneca Plc to develop and commercialize its late-stage experimental psoriasis drug brodalumab. The arrangement excludes Japan and certain other Asian countries where rights are held by Kyowa Hakko Kirin Co, Valeant said on Tuesday.

  • Yahoo CEO Marissa Mayer says expecting twin girls Tuesday, 1 Sep 2015 | 1:54 AM ET

    Sept 1- Yahoo Chief Executive Marissa Mayer is pregnant with identical twin girls, likely due in December, she said in a blog post. "Since this is a unique time in Yahoo's transformation, I plan to approach the pregnancy and delivery as I did with my son three years ago, taking limited time away and working throughout," Mayer wrote in a post early Tuesday.

  • Google, Sanofi team up to improve diabetes care Monday, 31 Aug 2015 | 10:26 AM ET

    Aug 31- Google Inc and French drugmaker Sanofi SA said they will partner to develop tools to improve the management and treatment of diabetes. Sanofi will work with Google's life sciences team to collect, analyze and understand information impacting diabetes, which is expected to affect 592 million by 2035, according to the International Diabetes...

  • How to take control of medical bills Friday, 28 Aug 2015 | 9:00 AM ET
    How to take control of medical bills

    One in three consumers has trouble paying medical bills. CNBC consumer reporter Kelli Grant offers tips on how to avoid the troubles.

  • Amgen wins approval for second biotech cholesterol drug Thursday, 27 Aug 2015 | 5:18 PM ET

    WASHINGTON— Amgen Inc. has won federal approval for the second medicine in a new class of pricey biotech drugs that reduce artery-clogging cholesterol more than older statin drugs that have been used for decades. Thousand Oaks, California- based Amgen priced the drug slightly below a similar drug Praluent, which costs $14,600 per year. Sanofi and partner...

  • Steven Musser, deputy director for scientific operations at the U.S. Food and Drug Administration's Center for Food Safety and Applied Nutrition. Now, the FDA is building a network of state and federal labs equipped to map out the exact DNA sequence of strains of Listeria, Salmonella and other foodborne pathogens found in sick patients. At the same time, the FDA...

  • Getting a flu shot? There are new options Wednesday, 26 Aug 2015 | 4:07 PM ET

    TRENTON, N.J.— People planning on getting a flu shot this season have several options to discuss with their doctors. Three vaccines may appeal to people squeamish about the inch-long needles typically used to give flu shots. Another option gives a high dosage for those needing extra protection.

  • Novo Nordisk adding diabetes drug output in NC, Denmark Wednesday, 26 Aug 2015 | 10:39 AM ET

    RALEIGH, N.C.— Danish drug maker Novo Nordisk said Wednesday it will open new factories in North Carolina and Denmark as pharmaceutical companies seek to keep up with demand for diabetes medications in an increasingly overweight world. Novo Nordisk plans to invest about $2 billion over the next five years in new production facilities in the Raleigh suburb of...

  • COPENHAGEN, Aug 26- Novo Nordisk said on Wednesday it would begin a Phase III trial of its treatment for diabetes that could be taken orally rather than by injection after "encouraging" results in previous trials. The oral tablet is a part of Novo Nordisk's effort to make treatment less painful for diabetes patients and minimize the use of needles.

  • INDIANAPOLIS— Shares of Eli Lilly rose Wednesday in premarket trading a day after the drugmaker said a federal court upheld a patent protecting one of its top-selling drugs, the cancer treatment Alimta. The Indianapolis company said Tuesday after markets closed that the U.S. District Court for the Southern District of Indiana ruled in Lilly's favor...

  • DES MOINES, Iowa— To protect a flock of rare chickens from the possibility of getting the bird flu, Iowa State University said Monday it has canceled classes for about 500 students at its poultry teaching and research farm. The Department of Animal Science is minimizing traffic to the poultry farm on 11 acres 3 miles south of the main Iowa State campus in Ames amid...

  • Amgen files for approval of parathyroid disorder drug Tuesday, 25 Aug 2015 | 1:13 PM ET

    NEW YORK— Biotech drugmaker Amgen said Tuesday it filed for marketing approval of a drug designed to treat a symptom of chronic kidney disease. Amgen asked the Food and Drug Administration to approve its drug etelcalcetide as a treatment for secondary hyperparathyroidism, a condition that can cause fragile bones, pain, and organ damage. The Thousand Oaks,...

  • Aug 21- The chief executive officer of biotechnology company Northwest Biotherapeutics Inc said on Friday the company has temporarily stopped screening new patients for the late-stage trial of its experimental brain cancer drug. The study, among patients with newly diagnosed brain cancer, is being conducted in Germany, the United Kingdom, the United States...